Evidence map›Paper›PMID 38392297›Full record

ReviewBiology2024

General Overview of

Rim Abbas, Mohamed Chakkour, Hiba Zein El Dine, Eseiwi Folorunsho Obaseki, Soumaya T Obeid, Aya Jezzini, Ghassan Ghssein, Zeinab Ezzeddine

Abstract readReview
In one paragraph

Review in Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Prevalence and Antimicrobial Resistance ofInfectious disease reports · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Monoclonal Antibodies Targeting Bacterial Infections: A Broad Review of the Field.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Characterization of the Fiber Protein C-Terminal Domain fromInternational journal of molecular sciences · 2026
    Article
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rim AbbasFaculty of Health Sciences, Beirut Arab University, Beirut P.O. Box 11-5020, Lebanon.
Mohamed ChakkourDepartment of Biological Sciences, Wayne State University, Detroit, MI 48202, USA.
Hiba Zein El DineDepartment of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland.
Eseiwi Folorunsho ObasekiDepartment of Biological Sciences, Wayne State University, Detroit, MI 48202, USA.
Soumaya T ObeidLaboratory Sciences Department, Faculty of Public Health, Islamic University of Lebanon (IUL), Khalde P.O. Box 30014, Lebanon.
Aya JezziniLaboratory Sciences Department, Faculty of Public Health, Islamic University of Lebanon (IUL), Khalde P.O. Box 30014, Lebanon.
Ghassan GhsseinLaboratory Sciences Department, Faculty of Public Health, Islamic University of Lebanon (IUL), Khalde P.O. Box 30014, Lebanon.ORCID 0000-0002-9313-1418
Zeinab EzzeddineLaboratory Sciences Department, Faculty of Public Health, Islamic University of Lebanon (IUL), Khalde P.O. Box 30014, Lebanon.ORCID 0000-0001-8745-263X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The opportunistic pathogen

Indexed as

epidemiologyKlebsiella pneumoniaepathogenesissiderophores

Identifiers

PMID38392297
PMCPMC10886558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.